Group B Streptococcal Bacteriuria in Pregnancy: An Evidence-Based, Patient-Centered Approach to Care.
Robyn SchaferJulia C PhillippiPublished in: Journal of midwifery & women's health (2020)
Screening and management of group B streptococcus (GBS) bacteriuria in pregnancy aims to reduce the incidence of pyelonephritis and GBS-related neonatal morbidity and mortality. Universal screening and management of GBS bacteriuria in pregnancy are standards of care in the United States; however, some women may decline guideline-based recommendations for screening, treatment, or intrapartum antibiotic prophylaxis. This article uses a case study approach to discuss evidence-based, patient-centered care for GBS bacteriuria in pregnancy as well as ethical incorporation of individual patient preferences and values.
Keyphrases
- pregnancy outcomes
- preterm birth
- healthcare
- urinary tract infection
- palliative care
- quality improvement
- pregnant women
- pain management
- affordable care act
- type diabetes
- risk factors
- case report
- staphylococcus aureus
- clinical practice
- escherichia coli
- insulin resistance
- skeletal muscle
- chronic pain
- candida albicans
- biofilm formation
- breast cancer risk